Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Jun 19;24(10):2072–2080. doi: 10.1016/j.bbmt.2018.06.013

Table 3A:

Observed Day+100 VOD Incidence

Patients, n Patients developing VOD, n (%)
Total Cohort 13097 637 (4.86%)
Training Set
 Group A 2440 28(1.15%)
 Group B 2442 106 (4.34%)
 Group C 609 53 (8.70%)
 Group D 611 109(17.84%)
Validation Set
 Group A 2494 49 (1.96%)
 Group B 2461 109 (4.43%)
 Group C 576 56 (9.72%)
 Group D 614 88(14.33%)